185 related articles for article (PubMed ID: 2671505)
1. Effect of 3-week treatment with [D-Trp6, des-Gly-NH10(2)]LHRH ethylamide, aminoglutethimide, ketoconazole or flutamide alone or in combination on testicular, serum, adrenal and prostatic steroid levels in the dog.
Lacoste D; Caron S; Bélanger A; Labrie F
J Steroid Biochem; 1989 Aug; 33(2):233-42. PubMed ID: 2671505
[TBL] [Abstract][Full Text] [Related]
2. The rise in testicular androgens during the first days of treatment with an LHRH agonist in the dog can be blocked by aminoglutethimide or ketoconazole.
Lacoste D; St-Arnaud R; Caron S; Belanger A; Labrie F
J Steroid Biochem; 1988 Dec; 31(6):963-70. PubMed ID: 3059065
[TBL] [Abstract][Full Text] [Related]
3. Effect of 2-week combination therapy with the luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide and the antiandrogen flutamide on prostate structure and steroid levels in the dog.
Lacoste D; Dubé D; Bélanger A; Labrie F
Mol Cell Endocrinol; 1989 Dec; 67(2-3):131-8. PubMed ID: 2693158
[TBL] [Abstract][Full Text] [Related]
4. Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
Bélanger A; Labrie F; Dupont A; Brochu M; Cusan L
Clin Invest Med; 1988 Oct; 11(5):321-6. PubMed ID: 2972431
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of flutamide action on prostatic and testicular functions in the rat.
Marchetti B; Labrie F
J Steroid Biochem; 1988 Jun; 29(6):691-8. PubMed ID: 2838689
[TBL] [Abstract][Full Text] [Related]
6. Changes in plasma steroid levels after single administration of hCG or LHRH agonist analogue in dog and rat.
Tremblay Y; Belanger A
J Steroid Biochem; 1985 Mar; 22(3):315-20. PubMed ID: 2581068
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of the inhibitory effect of chronic treatment with an LHRH agonist on testicular steroidogenesis in the dog.
Tremblay Y; Bélanger A; Labrie F; Frenette G; Dubé JY; Tremblay RR
Prostate; 1984; 5(6):631-8. PubMed ID: 6208541
[TBL] [Abstract][Full Text] [Related]
8. Reversible inhibition of gonadal functions by a potent gonadotropin-releasing hormone agonist in adult dog.
Tremblay Y; Bélanger A
Contraception; 1984 Nov; 30(5):483-97. PubMed ID: 6394207
[TBL] [Abstract][Full Text] [Related]
9. Advantages of the combination therapy in previously untreated and treated patients with advanced prostate cancer.
Labrie F; Dupont A; Giguere M; Borsanyi JP; Belanger A; Lacourciere Y; Emond J; Monfette G
J Steroid Biochem; 1986 Nov; 25(5B):877-83. PubMed ID: 3100871
[TBL] [Abstract][Full Text] [Related]
10. Normal gonadal functions and fertility after 23 months of treatment of prepubertal male and female dogs with the GnRh agonist [D-Trp6, des-Gly-NH2(10)]GnRH ethylamide.
Lacoste D; Dubé D; Trudel C; Bélanger A; Labrie F
J Androl; 1989; 10(6):456-65. PubMed ID: 2695507
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: today's therapy of choice.
Labrie F; Dupont A; Cusan L; Giguere M; Bergeron N; Borsanyi JP; Lacourciere Y; Belanger A; Emond J; Monfette G
J Steroid Biochem; 1988; 30(1-6):107-17. PubMed ID: 3290578
[TBL] [Abstract][Full Text] [Related]
12. The luteinizing hormone-releasing hormone (LHRH) agonist, [D-Trp6, des-Gly-NH2(10)]-LHRH ethylamide, has no direct effect on spermatogenesis in the rat.
Dubé D; Pelletier G; Labrie F
Biol Reprod; 1988 Jun; 38(5):1165-70. PubMed ID: 3044454
[TBL] [Abstract][Full Text] [Related]
13. Loss of luteinizing hormone bioactivity in patients with prostatic cancer treated with an LHRH agonist and a pure antiandrogen.
St-Arnaud R; Lachance R; Kelly SJ; Belanger A; Dupont A; Labrie F
Clin Endocrinol (Oxf); 1986 Jan; 24(1):21-30. PubMed ID: 3519004
[TBL] [Abstract][Full Text] [Related]
14. Recovery of gonadal functions in the adult male rat following cessation of five-month daily treatment with an LHRH agonist.
Lefebvre FA; Bélanger A; Pelletier G; Labrie F
J Androl; 1984; 5(3):181-92. PubMed ID: 6086556
[TBL] [Abstract][Full Text] [Related]
15. Modulation by sex steroids and [D-Trp6, Des-Gly-NH2(10)]luteinizing hormone (LH)-releasing hormone ethylamide of alpha-subunit and LH beta messenger ribonucleic acid levels in the rat anterior pituitary gland.
Simard J; Labrie C; Hubert JF; Labrie F
Mol Endocrinol; 1988 Sep; 2(9):775-84. PubMed ID: 2459604
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of spermatogenesis in the presence of normal libido following combined treatment with an LHRH agonist and testosterone in the dog.
Tremblay Y; Bélanger A; Lacoste D; Giasson M; Labrie F
Contraception; 1984 Dec; 30(6):585-8. PubMed ID: 6397329
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy in stage C and D prostatic cancer: rationale and five year clinical experience.
Labrie F; Dupont A; Bélanger A; Cusan L; Giguère M; Lacourcière Y; Luthy I; Bégin D; Labrie C; Simard J
Cancer Metastasis Rev; 1987; 6(4):615-36. PubMed ID: 3327635
[TBL] [Abstract][Full Text] [Related]
18. A pure antiandrogen does not interfere with the LHRH agonist-induced blockade of testicular androgen secretion in the dog.
Lacoste D; St-Arnaud R; Bélanger A; Labrie F
Mol Cell Endocrinol; 1988 Mar; 56(1-2):141-7. PubMed ID: 3286322
[TBL] [Abstract][Full Text] [Related]
19. Increased testicular 5 alpha-androstane-3 alpha, 17 beta-diol formation induced by treatment with [D-Ser (TBU) 6, des-Gly-NH2(10)] LHRH ethylamide in the rat.
Carmichael R; Bélanger A; Cusan L; Séguin C; Caron S; Labrie F
Steroids; 1980 Oct; 36(4):383-91. PubMed ID: 6255633
[TBL] [Abstract][Full Text] [Related]
20. Specificity of the direct effect of an LHRH agonist on testicular 17-hydroxylase but not on 5 alpha-reductase activity in hypophysectomized adult rats.
Tremblay Y; Bélanger A; Marchetti B
Mol Cell Endocrinol; 1985 Apr; 40(1):33-40. PubMed ID: 3922824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
